Response to “Unexpected mutations after CRISPR-Cas9 editing in vivo”
biorxiv.org
biorxiv.org
Why didn't they just take samples from the mouse before and after?
FWIW, anti-p-hacking measures are already implemented for clinical trials; they have to register expected outcomes at the beginning.
The whole value for a journal is to be able to select once the results are known because that's how you build prestige.
All you are doing in effect is to lay out a good case why journals should and probably will simply die because this level of transparency would be a great thing to have but is incompatible with the publishers model.
Another way of thinking about a journal's incentives is that, by moving the primary peer-review stage before a study has actually been conducted, you greatly expand the number of studies that a journal will interact with, which may provide a larger and more valuable role for entities like journals in world where actual publishing is a trivial matter.
Yes, hence the blockchain, which provides all that in a fairly convenient package.
You could even piggyback on any existing public blockchain, for a few fractions of a penny.
In pre-registration a trusted intermediary is used to store a read-only copy of your study design and materials, ideally including a pre-analysis plan that specifies the analysis you will run for hypothesis testing (so that we can cut P-hacking out of the picture at the same time). That intermediary can allow researchers to withdraw registrations while preserving a stub that shows everyone a registration used to be there and why it was removed.
That is how pre-registrations work on the Open Science Framework (https://osf.io), a cross-disciplinary FOSS web tool run by the Center for Open Science.
No other problem in science is more important to solve.
When I used to run a lab we used to only consider results that had been replicated in at least two unconnected labs. Everything else was just a waste of time (on average).
Once you have enough observations, then you start forming and testing hypothesis.
"Here we provide additional confirmatory data and clarifying discussion, including sequencing data showing extensive heterozygous mutations throughout the genome in the CRISPR treated mice, which are all progeny of inbred mice purchased from a commercial vendor (JAX). The heterozygosity in these cases cannot be parentally inherited. The summary statements in our Correspondence reflect observations of a secondary outcome following successful achievement of the primary outcome using CRISPR to treat blindness in Pde6b/rd1 mice. As the scientific community considers the role of WGS in off-target analysis, future in vivo studies are needed where the design and primary outcome focuses on CRISPR off-targeting. We agree that a range of WGS controls are needed that include parents, different gRNAs, different versions of Cas9, and different in vivo protocols. We look forward to the publication of such studies. Combined, these results will be essential to fully understand off-targeting and can be used to create better algorithms for off-target prediction. Overall, we are optimistic that some form of CRISPR therapy will be successfully engineered to treat blindness."
>"In our case, 56 zygotes were harvested from six pregnant females bred to six stud males and injected with CRISPRCas9." http://www.biorxiv.org/content/early/2017/06/23/154450
So they started with 56 zygotes, of which 11 survived injection of Crispr/etc. Of these 11, five and two mice showed some evidence of containing NHEJ/HDR cells, respectively.
In the case of NHEJ, they do not tell us what percent of cells were "edited" per mouse (or I missed it when I read that paper earlier). However for HDR it was only about 1/3 and 1/5 for the two mice they found. So this suggests the "editing" is occurring not at the zygote stage, but somewhat later (based on the percentages, perhaps at the 4 or 8 cell stages).
Assuming the edit/mouse rate is similar for NHEJ and HDR (somewhat dubious), it looks like 4x56 = 224 to 8x56 = 448 cells were treated with crispr/etc and ~ 7 got "edited". This gives ~1-3% "edits" per treated cell.
I've seen first hand how the peer review system works in the United States. Foreign Postdocs studying in the United States are desperate for a Green Card. They peer review as many papers as they can as quickly as they can to prove something or other for the purposes of a securing a Green Card. Some of these foreign postdocs do a good job, many do not. Also, overworked professors don't always take the time to carefully read a paper and don't care. The result is that a lot papers make it through peer review that shouldn't.
I'd rather have my paper peer reviewed live on the internet by allowing people to comment on it beneath a PDF link than to suffer through another drawn out peer review process. People who care have a text-box where they say what they want, and if no one cares then it indicates I need to do research on something else!
Reviewing a paper is mostly charity and gets you nothing in return, except the fact that when you submit a paper, someone will do the same. It does not help in the Green Card process at all, or boosts your academic credentials.
Regarding overworked professors, they are allowed to delegate reviews internally to students to ease the time they have to spend.
What about PhDs? You've never seen PhDs review papers in CS? It happens for prestigious conferences too.
Also your pointing fingers at foreigners is quite disturbing. Why you think they caused the problem? Do you have any evidence? I don't think in any academic workplace you can say this without unfavorable consequence.
Your last line is one of the most frustrating parts of academia. Not being able to criticize misaligned incentives simply because it involves foreigners is crazy.
I don't know why you summarize my lines this way. I basically want to know whether he can offer some evidence to support that idea.
I have never heard of this. No-one knows if you review a paper, it has no bearing on your job security or your visa status, this post is baffling
s/broke/broken/
(unless you meant bankrupt, then broke is fine).
> Foreign Postdocs studying in the United States are desperate for a Green Card. They peer review as many papers as they can as quickly as they can to prove something or other for the purposes of a securing a Green Card. Some of these foreign postdocs do a good job, many do not. Also, overworked professors don't always take the time to carefully read a paper and don't care. The result is that a lot papers make it through peer review that shouldn't.
Well, it's unfortunate that you seem to have experienced the worst review processes. It is also unfortunate that you automatically assume that it's _foreign_ postdocs that are doing the shoddy work. Maybe you had bad luck, or maybe you're oversimplifying for the sake of argument, dunno, but that does not jive very well with what I've seen, all the way up from being a student author, student reviewer, reviewer, PC member, journal reviewer, and Program Chair of a conference.
At least in CS, the number of reviews done by postdocs is not a large percentage. Most PCs are composed of academic and industry researchers, primarily professors and professionals, and increasingly reviewers are no longer allowed to use sub-reviewers without attribution. The number of postdoc PC members is low; and for good reason. Postdocs typically last less than two years, and during this period they are more focused on publishing their own research as a last push to improve their academic standing before finding a job. I get the impression that it's known that postdocs are too busy to do a good job at reviewing.
> I'd rather have my paper peer reviewed live on the internet by allowing people to comment on it beneath a PDF link...
I guess you never had a Boaty McBoatface moment. I think open review without experts would be disastrous, as the nitty gritty fine details that absolutely have to be right should be vetted carefully by experts, rather than spending forever in a shouting match with the loudest voices in the crowd. Can you imagine peer review by YouTube comments? shudder
Don't know about that, but the inbred cloned mouse business seems to have quality control issues.